Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SECOND SIGHT MEDICAL PRODUCTS, INC.

(EYES)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/29/2021 11/30/2021 12/01/2021 12/02/2021 12/03/2021 Date
2.05(c) 1.98(c) 1.85(c) 1.94(c) 1.8 Last
627 211 565 028 596 076 619 210 599 212 Volume
-1.91% -3.41% -6.57% +4.86% -7.22% Change
More quotes
Estimated financial data (e) (USD)
Sales 2019 3,38 M - -
Net income 2019 -33,6 M - -
Net cash position 2019 8,73 M - -
P/E ratio 2019 -2,60x
Yield 2019 -
Sales 2020 - - -
Net income 2020 -14,9 M - -
Net cash position 2020 0,98 M - -
P/E ratio 2020 -2,59x
Yield 2020 -
Capitalization 70,9 M 70,9 M -
EV / Sales 2019 24,8x
EV / Sales 2020 -
Nbr of Employees 15
Free-Float 74,8%
More Financials
Company
Second Sight Medical Products, Inc. is engaged in developing, manufacturing and marketing implantable visual prosthetics devices that restore vision to blind individuals. The Company manufactures neuromodulation devices for blindness and engaged in developing new technologies to treat sight-impaired individuals. Its approved product, the Argus II Retinal Prosthesis System (Argus II), treats outer retinal... 
More about the company
All news about SECOND SIGHT MEDICAL PRODUCTS, INC.
11/12SECOND SIGHT MEDICAL PRODUCTS INC Management's Discussion and Analysis of Financial Co..
AQ
11/12Second Sight Medical Products, Inc. Reports Earnings Results for the Third Quarter and ..
CI
09/20SECOND SIGHT MEDICAL PRODUCTS, INC.( : EYES) added to S&P Global BMI Index
CI
08/13SECOND SIGHT MEDICAL PRODUCTS : Management's Discussion and Analysis of Financial Conditio..
AQ
08/13Second Sight Medical Products, Inc. Reports Earnings Results for the Second Quarter End..
CI
08/11SECOND SIGHT MEDICAL PRODUCTS : Obtains New NIH Grant Supplement for Visual Neuroprosthese..
MT
08/11SECOND SIGHT MEDICAL PRODUCTS : Announces a New NIH Grant Supplement for Its Orion Study
BU
08/04SECOND SIGHT MEDICAL PRODUCTS INC : Other Events (form 8-K)
AQ
08/04Second Sight Medical Products, Inc. Receives Grant from the National Institutes of Heal..
CI
07/23NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
DJ
07/23Certain Warrants of Second Sight Medical Products, Inc. are subject to a Lock-Up Agreem..
CI
07/23Certain Common Stock of Second Sight Medical Products, Inc. are subject to a Lock-Up Ag..
CI
07/23Certain Stock Options of Second Sight Medical Products, Inc. are subject to a Lock-Up ..
CI
07/16NORTH AMERICAN MORNING BRIEFING : Retail Sales -3-
DJ
07/09NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
DJ
More news
News in other languages on SECOND SIGHT MEDICAL PRODUCTS, INC.
06/25Second Sight Medical Products clôture son offre d'actions ordinaires
06/23MISE À JOUR SECTORIELLE : Les actions du secteur de la santé en baisse cet après-midi
06/23MISE À JOUR SECTORIELLE : Les actions du secteur de la santé chutent alors que les biotech..
06/23Wall Bourse progresse avant la cloche ; Futures verts, Europe en baisse, Asie en hausse
06/23Second Sight Medical fixe le prix de son offre publique à 5 dollars par action et prévo..
More news
Chart SECOND SIGHT MEDICAL PRODUCTS, INC.
Duration : Period :
Second Sight Medical Products, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SECOND SIGHT MEDICAL PRODUCTS, INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Managers and Directors
Scott Dunbar Chief Executive Officer
Gregg G. Williams Chairman
Jessy Dorn Vice President-Clinical & Scientific Affairs
Edward Randolph Vice President-Operations
Aaron Mendelsohn Independent Director